Insights

Recent Generic Launches Par Pharmaceutical has recently launched generic versions of popular medications, including DUEXIS. This presents an opportunity to target healthcare providers and pharmacies looking for cost-effective alternatives for their patients.

Partnership Opportunities Par Pharmaceuticals has a history of partnerships with other companies in the industry like Sucampo Pharmaceuticals and Indivior PLC. Leveraging these existing relationships and exploring new collaborations could open doors to new sales channels and innovations.

Asset Sale Potential With the recent sale of manufacturing and laboratory equipment, Par Pharmaceutical may be looking to update and enhance its infrastructure. This could signal opportunities for equipment suppliers or service providers to offer their solutions to support Par's operations.

Patent Challenges The legal challenges faced by Par Pharmaceuticals regarding patent infringement indicate a focus on introducing generic versions of existing drugs. Sales teams can target pharmaceutical companies facing similar patent issues and offer collaborative solutions or alternative products.

R&D Pipeline Par Pharmaceutical is advancing a robust research and development pipeline. Engaging with the company early on to understand their upcoming product offerings could allow for tailored sales pitches and partnerships as new products reach the market.

Similar companies to Par Pharmaceutical

Par Pharmaceutical Tech Stack

Par Pharmaceutical uses 8 technology products and services including BugSnag, SAP, Salesforce, and more. Explore Par Pharmaceutical's tech stack below.

BugSnag
Analytics
SAP
Customer Relationship Management
Salesforce
Customer Relationship Management
Microsoft Excel
Editors
Google Cloud
Infrastructure As A Service
ipify
Mapping And Gis
Webpack
Miscellaneous
Amazon Web Services
Platform As A Service

Media & News

Par Pharmaceutical's Email Address Formats

Par Pharmaceutical uses at least 1 format(s):

Par Pharmaceutical Email Formats	Example	Percentage
First.Last@parpharm.com	John.Doe@parpharm.com	65%
L.First@parpharm.com	D.John@parpharm.com	25%
FLast@parpharm.com	JDoe@parpharm.com	8%
First.L@parpharm.com	John.D@parpharm.com	2%

Frequently Asked Questions

Where is Par Pharmaceutical's headquarters located?

Par Pharmaceutical's main headquarters is located at 1 Ram Ridge Road Chestnut Ridge, NY 10977 US. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is Par Pharmaceutical's stock symbol?

Par Pharmaceutical is a publicly traded company; the company's stock symbol is PRX.

What is Par Pharmaceutical's official website and social media links?

Par Pharmaceutical's official website is parpharm.com and has social profiles on LinkedIn.

How much revenue does Par Pharmaceutical generate?

As of November 2024, Par Pharmaceutical's annual revenue reached $935M.

What is Par Pharmaceutical's SIC code NAICS code?

Par Pharmaceutical's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 325412 - Pharmaceutical Preparation Manufacturing.

How many employees does Par Pharmaceutical have currently?

As of November 2024, Par Pharmaceutical has approximately 1.5K employees across 6 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: B. B.Chief Executive Officer: J. E.Chief Executive Officer: L. M.. Explore Par Pharmaceutical's employee directory with LeadIQ.

What industry does Par Pharmaceutical belong to?

Par Pharmaceutical operates in the Pharmaceutical Manufacturing industry.

What technology does Par Pharmaceutical use?

Par Pharmaceutical's tech stack includes BugSnagSAPSalesforceMicrosoft ExcelGoogle CloudipifyWebpackAmazon Web Services.

What is Par Pharmaceutical's email format?

Par Pharmaceutical's email format typically follows the pattern of . Find more Par Pharmaceutical email formats with LeadIQ.

When was Par Pharmaceutical founded?

Par Pharmaceutical was founded in 1978.

Par Pharmaceutical

Pharmaceutical ManufacturingNew York, United States1001-5000 Employees

Par Pharmaceutical: High-Quality, Cost-Effective Generic Products

Par Pharmaceutical, headquartered in Chestnut Ridge, New York, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical and branded injectable products that help improve patient quality of life. Par, among the top leaders in the U.S. generics industry, possesses a portfolio that includes sterile injectables, alternative dosage forms and many other differentiated products. Par is advancing a robust research and development (R&D) pipeline of potential products.  Par is an operating company of Endo International plc, a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients through excellence in development, manufacturing and commercialization.